Page 45 of Dose

Two seconds later, his tablet chimes. He reads the message and sets down his coffee. “Council business. Raphael, apologies.”

“Breakfast is not suspended for bad news,” Raphael says. “Talk while they chew.”

Marcus sends the intelligence display to the wall. The room reorganizes around it without anyone being told. Intercepts. Movement orders. A map crowded with red markers.

“Two developments,” Marcus says. “The search pattern has moved west. Korte’s analysts connected Ashford to two of our earlier operations—the Philadelphia acquisition and the Detroit financial pull—and built a model of our operational tempo. They are no longer asking only where Isla went. They are using our past activity to narrow where we stage from.”

He expands the map.

“Second, the program is hardening its network. Personnel transfers to six facilities in the past seventy-two hours. Security upgrades at four. Pharmaceutical relocations from at least three regional stores.”

“They’re redistributing before we can use Ashford,” Ezra says. He has stopped eating. His fingers move across one tablet. “If they alter staffing and inventory far enough, our facility models become stale. Every site has to be mapped again.”

“How long?” Nikolai asks.

“Four weeks before confidence drops below operational threshold. Five if their logistics are as slow as usual.”

“How many known facilities?” Damon asks.

“Seventeen,” Marcus says. “Likely hundreds of children across the network.”

The number changes the room. Raphael’s hands go still around the dish towel. Lucien looks up. The humor leaves Darius so completely that I see the man beneath it.

Pressure gathers behind my sternum.

I know something they do not.

“The pharmaceutical relocations,” I say. “Do the manifests identify temperature controls?”

Marcus checks. “They’re coded. Two consignments require refrigerated transport. Why?”

“Because the relocation itself may show you the network.” I set down my fork. “The program presents its pharmaceutical chain as distributed, but production is centralized. Most facilities can store and administer. They cannot synthesize.”

Ezra’s hands stop moving.

“How centralized?” he asks.

“Three validated synthesis hubs, all inside the United States. Site Nine is one. Several V-series formulations require a two-to-eight-degree cold chain, and the individualized lots move on short schedules. The end facilities keep limited working stock because centralized supply is another form of control. Korte does not allow them enough independence to survive for long without a hub.”

“How long is limited?” Theon asks. His voice has gone careful.

“It varies by compound and site. Two weeks for some maintenance agents. Six to eight for the more stable lots. We would need current manifests before relying on any estimate.”

“If the hubs stop,” Damon says, “the sites surface when they scramble for supply.”

“Yes, but we cannot simply stop them.” I look at Theon. “Some of those children are physically dependent. Abrupt interruption would cause panic, seizures, possibly death. The hubs are not demolition targets. They are the map.”

Ezra is typing again.

I rise and approach the display. “Every outgoing lot carries a destination code, a dosing profile, and a cold-chain record. If you gain access to one hub’s logistics system without alerting the network, you expose the facilities it supplies. If you compromise all three, you can trace nearly every active site.”

“And control the shipments,” Marcus says.

“Monitor them first. Divert or replace them only when medical teams and taper stock are ready. The system has to come apart in sequence.” I point to the relocation routes. “Ashford could store and administer, but it could not produce. That is why my audit mattered. Most facilities are endpoints. The hubs tell you where the endpoints are.”

Nikolai studies the map. “You said you could identify all three.”

“I can identify Site Nine exactly. I ran its V-series line for six years.” The old shame rises, acidic and familiar. I use it. “The other two appeared in cross-validation packages and deviation reports. I know their cities, equipment lists, production capacity, suppliers, and portions of their clean-room layouts. I can mark what I know directly, what I inferred, and how confident I am in each item.”